2016 Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Saraceni F Journal J Hematol Oncol.
2016 Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an Acute Leukemia Working Party-EBMT study. Group Acute Leukemia Working Party (ALWP) 1st listed author Ruggeri A Journal J Hematol Oncol.
2016 Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the acute leukemia working party (Acute Leukemia Working Party) of the European group of blood and marrow transplantation (EBMT). Group Acute Leukemia Working Party (ALWP) 1st listed author [No authors listed] Journal Am J Hematol.
2016 Post-transplant cyclophosphamide versus antithymocyte-globulin as graft versus host disease prophylaxis in haploidentical transplant. Group Acute Leukemia Working Party (ALWP) 1st listed author Ruggeri A Journal Haematologica
2016 Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study. Group Acute Leukemia Working Party (ALWP) 1st listed author Shouval R Journal PLoS One.
2016 Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Giebel S Journal Oncologist.
2015 Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood-a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) Cellular Therapy & Immunobiology Working Party (CTIWP) Other society 1st listed author Baron F Journal J Hematol Oncol.
2015 Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Passweg JR Journal Bone Marrow Transplant.
2015 Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Schmid C Journal Blood
2015 Definition of GvHD-free, relapse-free survival for registry-based studies: an Acute Leukemia Working Party-EBMT analysis on patients with AML in remission. Group Acute Leukemia Working Party (ALWP) 1st listed author Ruggeri A Journal Bone Marrow Transplant.
2015 Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis. Group Acute Leukemia Working Party (ALWP) 1st listed author Nagler A Journal Lancet Haematol.
2015 Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Kharfan-Dabaja MA Journal Leuk Res.